Literature DB >> 2052492

Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen.

P Sacerdote1, C J Wiedermann, L M Wahl, C B Pert, M R Ruff.   

Abstract

Direct radioreceptor binding experiments and Scatchard analysis reveal CCK receptors on elutriator purified human peripheral blood monocytes, but not on purified human T cells. The monocyte receptors have a single class of high (0.1 nM) affinity binding sites. A structure-function analysis of monocyte binding by different CCK analogs correlates well with previously demonstrated chemotactic responses in monocytes and receptors in brain tissue. Biochemical cross-linking indicates that the monocyte CCK recognition molecule is comparable in molecular size to that in brain membranes. Utilizing a novel fluoresceinated Texas Red-CCK conjugate we have visualized that up to 20% of human peripheral monocytes bear receptors for CCK. A discrete and anatomically significant distribution of CCK receptors in rat spleen is shown by film autoradiography of tissue sections. A more detailed microscopic analysis identifies a dendritic population of monocyte-derived cells within the periarteriolar lymphocyte sheath (PALS) of the white pulp as the CCK receptor-bearing cell in spleen. The anatomical localization of receptor-bearing cells within the PALS region suggests a role for CCK in the antigen processing and sensitization phases of the immune response via regulatory effects of this peptide on a specific, local macrophage-related cell population.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052492     DOI: 10.1016/0196-9781(91)90184-q

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.

Authors:  S A Wank; J R Pisegna; A de Weerth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Gastrin-deficient mice have disturbed hematopoiesis in response to iron deficiency.

Authors:  Suzana Kovac; Gregory J Anderson; Warren S Alexander; Arthur Shulkes; Graham S Baldwin
Journal:  Endocrinology       Date:  2011-06-07       Impact factor: 4.736

3.  Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

Authors:  D S Weinberg; B Ruggeri; M T Barber; S Biswas; S Miknyocki; S A Waldman
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Cholecystokinin protects rats against sepsis induced by Staphylococcus aureus.

Authors:  Fabiana Maria das Graças Corsi Zuelli; Evelin Capellari Cárnio; Rafael Simone Saia
Journal:  Med Microbiol Immunol       Date:  2014-02-01       Impact factor: 3.402

Review 5.  Gastrin, inflammation, and carcinogenesis.

Authors:  Celia Chao; Mark R Hellmich
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-02       Impact factor: 3.243

6.  Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin.

Authors:  Satoshi Miyamoto; Kenichi Shikata; Kyoko Miyasaka; Shinichi Okada; Motofumi Sasaki; Ryo Kodera; Daisho Hirota; Nobuo Kajitani; Tetsuharu Takatsuka; Hitomi Usui Kataoka; Shingo Nishishita; Chikage Sato; Akihiro Funakoshi; Hisakazu Nishimori; Haruhito Adam Uchida; Daisuke Ogawa; Hirofumi Makino
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

7.  Cholecystokinin inhibits inducible nitric oxide synthase expression by lipopolysaccharide-stimulated peritoneal macrophages.

Authors:  Rafael Simone Saia; Fabíola Leslie Mestriner; Giuliana Bertozi; Fernando Queiróz Cunha; Evelin Capellari Cárnio
Journal:  Mediators Inflamm       Date:  2014-07-13       Impact factor: 4.711

Review 8.  Metabolic Hormones Modulate Macrophage Inflammatory Responses.

Authors:  Matthew J Batty; Gwladys Chabrier; Alanah Sheridan; Matthew C Gage
Journal:  Cancers (Basel)       Date:  2021-09-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.